J. Biol. Chem., Vol. 262, Issue 33, 15813-15816, Nov, 1987

Immunological identity of heparin-dependent plasma and urinary protein C inhibitor and plasminogen activator inhibitor-3

MJ Heeb, F Espana, M Geiger, D Collen, DC Stump and JH Griffin
Research Institute of Scripps Clinic, La Jolla, California 92037.

Purified plasma and urinary protein C inhibitors (PCI) formed heparin- dependent complexes with activated protein C (APC) which were detected by immunoblotting after nondenaturing gel electrophoresis. Bands representing APC.PCI complexes were also seen on immunoblots after incubation of plasma with APC and heparin. The same immunoblot pattern of complexes was detected by three different methods: method A, monoclonal antibody to plasminogen activator inhibitor-3 (PAI-3, urinary urokinase inhibitor) + 125I-labeled anti-mouse IgG; method B, polyclonal antibodies to PCI + 125I-labeled purified plasma PCI; and method C, monoclonal antibody to protein C + 125I-protein C. Plasma depleted of PAI-3 by immunoadsorption with insolubilized monoclonal antibody to PAI-3 showed no detectable antigen or complexes with APC as visualized by methods A or B. This PAI-3-depleted plasma had less than 10% of the heparin-dependent inhibitory activity of normal plasma toward APC. Purified plasma PCI was fully reactive in an enzyme-linked immunoabsorbent assay for PAI-3, and plasma and urinary PCI inhibited urokinase activity in a heparin-dependent manner. These data indicate that heparin-dependent plasma and urinary PCI and PAI-3 are immunologically and functionally very similar if not identical. This observation identifies a new interrelation between the protein C anticoagulant and the fibrinolytic systems. In addition, plasma contains a heparin-independent inhibitor of APC which is not immunologically related to plasma PCI or to PAI-3.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. Ramon, J. Gilabert-Estelles, R. Castello, J. Gilabert, F. Espana, A. Romeu, M. Chirivella, J. Aznar, and A. Estelles mRNA analysis of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis using a real-time quantitative RT-PCR assay Hum. Reprod., January 1, 2005; 20(1): 272 - 278. [Abstract] [Full Text] [PDF]

				J. Gilabert-Estelles, A. Estelles, J. Gilabert, R. Castello, F. Espana, C. Falco, A. Romeu, M. Chirivella, E. Zorio, and J. Aznar Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis Hum. Reprod., July 1, 2003; 18(7): 1516 - 1522. [Abstract] [Full Text] [PDF]

				B. S. Schwartz and F. Espana Two Distinct Urokinase-Serpin Interactions Regulate the Initiation of Cell Surface-associated Plasminogen Activation J. Biol. Chem., May 21, 1999; 274(21): 15278 - 15283. [Abstract] [Full Text] [PDF]

				J. Nishioka, M. Ning, T. Hayashi, and K. Suzuki Protein C Inhibitor Secreted from Activated Platelets Efficiently Inhibits Activated Protein C on Phosphatidylethanolamine of Platelet Membrane and Microvesicles J. Biol. Chem., May 1, 1998; 273(18): 11281 - 11287. [Abstract] [Full Text] [PDF]

				M. G.L.M. Elisen, P. A.Kr. von dem Borne, B. N. Bouma, and J. C.M. Meijers Protein C Inhibitor Acts as a Procoagulant by Inhibiting the Thrombomodulin-Induced Activation of Protein C in Human Plasma Blood, March 1, 1998; 91(5): 1542 - 1547. [Abstract] [Full Text] [PDF]